UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts

EBioMedicine, 2020-06, Vol.56, p.102815-102815, Article 102815

2020

Volltextzugriff (PDF)

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

The New England journal of medicine, 2015-08, Vol.373 (9), p.808-822

2015

Volltextzugriff (PDF)

Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24‐month prospective study in Côte d'Ivoire

Journal of the International AIDS Society, 2014-01, Vol.17 (1), p.18977-n/a

2014

Volltextzugriff (PDF)

Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1–Infected West African Adults With High CD4 Counts

Journal of acquired immune deficiency syndromes (1999), 2021-01, Vol.86 (1), p.138-145

2021

Volltextzugriff (PDF)

Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)

Scientific reports, 2024-05, Vol.14 (1), p.10244-10244, Article 10244

2024

Volltextzugriff (PDF)

Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation

Journal of antimicrobial chemotherapy, 2021-10, Vol.76 (10), p.2666-2674

2021

Volltextzugriff (PDF)

Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts

Journal of the International AIDS Society, 2013-04, Vol.16 (1), p.18059-n/a

2013

Volltextzugriff (PDF)

Twenty-Year Evolution of Hepatitis B Virus and Human Immunodeficiency Virus Prevalence and Incidence in Voluntary Blood Donors in Côte d’Ivoire

Open forum infectious diseases, 2018-04, Vol.5 (4), p.ofy060-ofy060

2018

Volltextzugriff (PDF)

Elite and viremic HIV-1 controllers in West Africa

AIDS (London), 2022-01, Vol.36 (1), p.29-38

2022

Volltextzugriff (PDF)

Ad-IFNγ Induces Antiproliferative and Antitumoral Responses in Malignant Mesothelioma

Clinical cancer research, 2002-10, Vol.8 (10), p.3298-3304

2002

Volltextzugriff (PDF)

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire

Antiviral therapy, 2015, Vol.20 (6), p.643-654

2015

Volltextzugriff (PDF)

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

The Lancet global health, 2017-11, Vol.5 (11), p.e1080-e1089

2017

Volltextzugriff (PDF)

Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial

The Lancet infectious diseases, 2021-06, Vol.21 (6), p.813-822

2021

Volltextzugriff (PDF)

WHO guidelines for antiretroviral therapy in serodiscordant couples in sub-Saharan Africa: how many fit?

AIDS (London), 2014-06, Vol.28 (10), p.1533-1535

2014

Volltextzugriff (PDF)

Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries

PloS one, 2016-04, Vol.11 (4), p.e0153243-e0153243

2016

Volltextzugriff (PDF)

Genotypic resistance profiles of HIV-2-treated patients in West Africa

AIDS (London), 2014-05, Vol.28 (8), p.1161-1169

2014

Volltextzugriff (PDF)

Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low‐ and middle‐income countries: a multicohort study

Journal of the International AIDS Society, 2019-09, Vol.22 (9), p.e25392-n/a

2019

Volltextzugriff (PDF)

Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation

AIDS (London), 2015-07, Vol.29 (12), p.1527-1536

2015

Volltextzugriff (PDF)

Missed opportunities for early access to care of HIV-infected infants in Burkina Faso

PloS one, 2014-10, Vol.9 (10), p.e111240-e111240

2014

Volltextzugriff (PDF)

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV co-infected patients from Côte d’Ivoire

Antiviral therapy, 2015, Vol.20 (6), p.643-654

2015

Volltextzugriff (PDF)

Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children

AIDS (London), 2014-07, Vol.28 (11), p.1645-1655

2014

Volltextzugriff (PDF)

Missed opportunities of inclusion in a cohort of HIV‐infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013

Journal of the International AIDS Society, 2016-01, Vol.19 (1), p.20601-n/a

2016

Volltextzugriff (PDF)

Immunologic response in treatment‐naïve HIV‐2‐infected patients: the IeDEA West Africa cohort

Journal of the International AIDS Society, 2016-01, Vol.19 (1), p.20044-n/a

2016

Volltextzugriff (PDF)

Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study

BMC infectious diseases, 2015-08, Vol.15 (1), p.317-317, Article 317

2015

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(25)
Humans
(24)
Female
(23)
Infectious Diseases
(22)
Male
(21)
Hiv Infections - Drug Therapy
(20)
Adult
(16)
Hiv
(16)
Human Immunodeficiency Virus
(16)
Immunology
(16)
Life Sciences
(14)
Santé Publique Et Épidémiologie
(12)
Drug Therapy
(11)
Acquired Immune Deficiency Syndrome
(10)
Aids
(10)
Antiretroviral Drugs
(10)
Aids/hiv
(9)
Antiretroviral Agents
(9)
Cd4 Lymphocyte Count
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Aids
(6)
Journal Of The International Aids Society
(6)
The Lancet Hiv
(3)
Antiviral Therapy
(2)
Bmc Infectious Diseases
(2)
Plos One
(2)
Ssrn Electronic Journal
(2)
The lancet. Hiv
(2)
Clinical Cancer Research
(1)
Ebiomedicine
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24‐month prospective study in Côte d'Ivoire

Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1–Infected West African Adults With High CD4 Counts

Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)

Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation

Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts

Twenty-Year Evolution of Hepatitis B Virus and Human Immunodeficiency Virus Prevalence and Incidence in Voluntary Blood Donors in Côte d’Ivoire

Elite and viremic HIV-1 controllers in West Africa

Ad-IFNγ Induces Antiproliferative and Antitumoral Responses in Malignant Mesothelioma

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study

Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial

WHO guidelines for antiretroviral therapy in serodiscordant couples in sub-Saharan Africa: how many fit?

Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries

Genotypic resistance profiles of HIV-2-treated patients in West Africa

Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low‐ and middle‐income countries: a multicohort study

Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation

Missed opportunities for early access to care of HIV-infected infants in Burkina Faso

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV co-infected patients from Côte d’Ivoire

Association between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected children

Missed opportunities of inclusion in a cohort of HIV‐infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013

Immunologic response in treatment‐naïve HIV‐2‐infected patients: the IeDEA West Africa cohort

Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study

Suchergebnisse filtern